- Home
- PMCB vs NVNI Comparison
PMCB vs NVNI Comparison
Compare PMCB & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- NVNI
- Stock Information
- Founded
- PMCB 1996
- NVNI 2019
- Country
- PMCB United States
- NVNI Brazil
- Employees
- PMCB N/A
- NVNI N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- NVNI
- Sector
- PMCB Health Care
- NVNI
- Exchange
- PMCB Nasdaq
- NVNI Nasdaq
- Market Cap
- PMCB 11.4M
- NVNI 10.4M
- IPO Year
- PMCB N/A
- NVNI N/A
- Fundamental
- Price
- PMCB $1.24
- NVNI $0.23
- Analyst Decision
- PMCB
- NVNI
- Analyst Count
- PMCB 0
- NVNI 0
- Target Price
- PMCB N/A
- NVNI N/A
- AVG Volume (30 Days)
- PMCB 15.0K
- NVNI 17.1M
- Earning Date
- PMCB 03-17-2025
- NVNI 05-07-2025
- Dividend Yield
- PMCB N/A
- NVNI N/A
- EPS Growth
- PMCB N/A
- NVNI N/A
- EPS
- PMCB 1.29
- NVNI N/A
- Revenue
- PMCB N/A
- NVNI $23,558,620.00
- Revenue This Year
- PMCB N/A
- NVNI $25.91
- Revenue Next Year
- PMCB N/A
- NVNI $17.52
- P/E Ratio
- PMCB $1.00
- NVNI N/A
- Revenue Growth
- PMCB N/A
- NVNI 38.59
- 52 Week Low
- PMCB $1.22
- NVNI $0.17
- 52 Week High
- PMCB $2.55
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- PMCB 30.59
- NVNI 29.92
- Support Level
- PMCB $1.22
- NVNI $0.20
- Resistance Level
- PMCB $1.40
- NVNI $0.29
- Average True Range (ATR)
- PMCB 0.13
- NVNI 0.03
- MACD
- PMCB -0.04
- NVNI 0.11
- Stochastic Oscillator
- PMCB 3.90
- NVNI 45.40
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.